Clinical Trial Update: Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing doxycycline for metakaryote cell death in patients with resectable pancreatic cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Resectable Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-07-03